Cardiol Therapeutics Inc. - COM CL A (CRDL)

Historical Portfolio Holders from Q4 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM CL A
Shares, excl. options Q3 2024
4.97M
Holdings value Q3 2024
$9.85M
Value change Q3 2024
-$780K
Grand Portfolio weight change Q3 2024
0%
Number of holders
40
Number of buys Q3 2024
16
Number of sells Q3 2024
-19
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 4.97M $9.85M -$780K $1.98 40
2024 Q2 5.39M $10.8M -$2.21M $2.02 40
2024 Q1 6.47M $11.5M +$17.2K $1.81 32
2023 Q4 6.83M $5.92M +$428K $0.84 30
2023 Q3 6.31M $5.7M -$336K $0.90 30
2023 Q2 6.68M $5.96M -$451K $0.89 29
2023 Q1 7.24M $3.54M +$179K $0.49 30
2022 Q4 5.64M $2.89M +$182K $0.51 27
2022 Q3 4.75M $4.89M -$535K $1.03 22
2022 Q2 5.28M $6.95M -$155K $1.32 24
2022 Q1 5.38M $8.26M -$920K $1.54 25
2021 Q4 5.79M $10.7M +$7.74M $1.85 27
2021 Q3 1.6M $6.6M +$6.6M $4.14 18
2021 Q1 0 $0 -$970K 0
2020 Q4 349K $970K +$171K $2.78 1
2020 Q3 287K $876K +$133K $3.05 1
2020 Q2 244K $577K +$78.3K $2.37 1
2020 Q1 210K $600K +$50.7K $2.85 1
2019 Q4 193K $681K $0 $3.53 1